Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01989585
Brief Title: Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

First Submitted : November 18, 2013
First Submitted that Met QC Criteria : November 18, 2013
First Posted : November 21, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : November 20, 2019
Last Update Posted : November 21, 2019